The Valley Desk

NCT04442737 · Interventional trial

A Study of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Evaluated as a Fixed Dose Combination Regimen in Participants Switching From an Integrase Inhibitor Who Have Experienced Rapid Weight Gain

Overall registry status Completed

Phase 4

Conditions HIV-1

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov